Literature DB >> 30683294

Novel SPECC1L-MET Fusion Detected in Circulating Tumor DNA in a Patient with Lung Adenocarcinoma following Treatment with Erlotinib and Osimertinib.

Annie W Nelson1, Alexa B Schrock2, Dean C Pavlick1, Siraj M Ali1, Emily C Atkinson3, Abraham Chachoua4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30683294     DOI： 10.1016/j.jtho.2018.10.160

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  6 in total

Review 1.  Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy.

Authors:  Kenichi Suda; Tetsuya Mitsudomi
Journal:  Transl Lung Cancer Res       Date:  2020-12

2.  Case Report: Dramatic Response to Crizotinib in a Patient With Non-Small Cell Lung Cancer Positive for a Novel ARL1-MET Fusion.

Authors:  Qing Ma; Lingping Kong; Diansheng Zhong
Journal:  Front Oncol       Date:  2022-02-14       Impact factor: 6.244

3.  Cytospin-A Regulates Colorectal Cancer Cell Division and Migration by Modulating Stability of Microtubules and Actin Filaments.

Authors:  Fan Fan; Jason Roszik; Ling Xia; Susmita Ghosh; Rui Wang; Xiangcang Ye; David Hawke; Lee M Ellis; Rajat Bhattacharya
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.639

4.  Case Report: Durable partial response to icotinib plus crizotinib in a lung adenocarcinoma patient with double uncommon EGFR G719D/L861Q mutations and an acquired novel CUX1-MET fusion.

Authors:  Lanzi Ou; Yicong Tang; Yanming Deng; Lijie Guo; Qingqing He; Tingting He; Weineng Feng
Journal:  Front Oncol       Date:  2022-07-26       Impact factor: 5.738

5.  Identification of prognostic markers of lung cancer through bioinformatics analysis and in vitro experiments.

Authors:  Bo Ling; Xianjiu Liao; Yuanhe Huang; Lingling Liang; Yan Jiang; Yaqin Pang; Guangzi Qi
Journal:  Int J Oncol       Date:  2019-11-28       Impact factor: 5.650

6.  Recurrent SPECC1L-NTRK fusions in pediatric sarcoma and brain tumors.

Authors:  Dong-Anh Khuong-Quang; Lauren M Brown; Marie Wong; Chelsea Mayoh; Alexandra Sexton-Oates; Amit Kumar; Mark Pinese; Sumanth Nagabushan; Loretta Lau; Louise E Ludlow; Andrew J Gifford; Michael Rodriguez; Jayesh Desai; Stephen B Fox; Michelle Haber; David S Ziegler; Jordan R Hansford; Glenn M Marshall; Mark J Cowley; Paul G Ekert
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.